Skip to main content
The BMJ logoLink to The BMJ
. 1995 Sep 9;311(7006):663–666. doi: 10.1136/bmj.311.7006.663

Review of prescribed treatment for children with asthma in 1990.

J O Warner 1
PMCID: PMC2551432  PMID: 7549637

Abstract

OBJECTIVE--To review treatment prescribed to asthmatic children in Great Britain during the 12 months after publication of the first guidelines and to assess effectiveness of prophylactic treatment. DESIGN--Review of prescribing information from January 1990 to June 1991 in a representative sample of general practices in Great Britain with a Compufile/AAH Meditel computer. SUBJECTS--17,846 children with asthma aged 4-17 years. MAIN OUTCOME MEASURES--Numbers of children prescribed different asthma treatments; estimated use of inhaled beta agonists in those receiving prophylactic treatment. RESULTS--From January to December 1990, 9,362 (52.5%) children were prescribed preventive treatments. 16,211 (90.8%) children were prescribed bronchodilators of some kind. 3,055 (17.1%) were prescribed sodium cromoglycate, and the proportion decreased significantly during the study (from 19.5% (95% confidence interval 18.6% to 20.4%) to 17.2% (16.4% to 18.1%), P < 0.001, in children aged 4-11 years and from 14.9% (14.0% to 15.9%) to 11.3% (10.4% to 12.2%), P < 0.001, in those aged 12-17 during January-July 1991). 6,952 (39.0%) were prescribed inhaled steroids, and the proportion increased during the study (from 35.1% (34.0% to 36.2%) to 44.1% (43.0% to 45.2%), P < 0.001, in children aged 4-11 years and from 38.7% (37.4% to 40.0%) to 44.1% (42.7% to 45.5%), P < 0.001, in those aged 12-17 during January-July 1991). Only 1,358 of the 9,362 children (14.5%) received sufficient repeat prescriptions to suggest that they might be taking the prophylactic treatment regularly. Among these children short acting inhaled beta agonists were being used on average four to eight times a day. CONCLUSIONS--These results are useful baseline data for audit of the impact of published clinical guidelines, particularly in terms of reducing the need for short acting inhaled beta agonists with prophylactic treatment.

Full text

PDF
663

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson H. R., Butland B. K., Strachan D. P. Trends in prevalence and severity of childhood asthma. BMJ. 1994 Jun 18;308(6944):1600–1604. doi: 10.1136/bmj.308.6944.1600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anderson S. D., Seale J. P., Rozea P., Bandler L., Theobald G., Lindsay D. A. Inhaled and oral salbutamol in exercise-induced asthma. Am Rev Respir Dis. 1976 Sep;114(3):493–500. doi: 10.1164/arrd.1976.114.3.493. [DOI] [PubMed] [Google Scholar]
  3. Beardon P. H., McGilchrist M. M., McKendrick A. D., McDevitt D. G., MacDonald T. M. Primary non-compliance with prescribed medication in primary care. BMJ. 1993 Oct 2;307(6908):846–848. doi: 10.1136/bmj.307.6908.846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chapman K. R., Kesten S., Szalai J. P. Regular vs as-needed inhaled salbutamol in asthma control. Lancet. 1994 Jun 4;343(8910):1379–1382. doi: 10.1016/s0140-6736(94)92520-8. [DOI] [PubMed] [Google Scholar]
  5. Godfrey S., Balfour-Lynn L., Tooley M. A three- to five-year follow-up of the use of the aerosol steroid, beclomethasone dipropionate, in childhood asthma. J Allergy Clin Immunol. 1978 Dec;62(6):335–339. doi: 10.1016/0091-6749(78)90133-1. [DOI] [PubMed] [Google Scholar]
  6. Hill R. A., Standen P. J., Tattersfield A. E. Asthma, wheezing, and school absence in primary schools. Arch Dis Child. 1989 Feb;64(2):246–251. doi: 10.1136/adc.64.2.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Jones K. New delivery systems for asthma drugs. Practitioner. 1989 Feb 22;233(1463):265–267. [PubMed] [Google Scholar]
  8. Kaarsgaren R. J., Zijlstra R. F., Helms P. Asthma medication in children-1991. Respir Med. 1994 May;88(5):383–386. doi: 10.1016/0954-6111(94)90045-0. [DOI] [PubMed] [Google Scholar]
  9. Law C. M., Marchant J. L., Honour J. W., Preece M. A., Warner J. O. Nocturnal adrenal suppression in asthmatic children taking inhaled beclomethasone dipropionate. Lancet. 1986 Apr 26;1(8487):942–944. doi: 10.1016/s0140-6736(86)91045-7. [DOI] [PubMed] [Google Scholar]
  10. Reiser J., Warner J. O. The value of participating in an asthma trial. Lancet. 1985 Jan 26;1(8422):206–207. doi: 10.1016/s0140-6736(85)92037-9. [DOI] [PubMed] [Google Scholar]
  11. Speight A. N., Lee D. A., Hey E. N. Underdiagnosis and undertreatment of asthma in childhood. Br Med J (Clin Res Ed) 1983 Apr 16;286(6373):1253–1256. doi: 10.1136/bmj.286.6373.1253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Warner J. O., Götz M., Landau L. I., Levison H., Milner A. D., Pedersen S., Silverman M. Management of asthma: a consensus statement. Arch Dis Child. 1989 Jul;64(7):1065–1079. doi: 10.1136/adc.64.7.1065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Warner J. O. The place of Intal in paediatric practice. Respir Med. 1989 May;83 (Suppl A):33–37. doi: 10.1016/s0954-6111(89)80248-3. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES